Literature DB >> 2216235

Removal of large symptomatic intrauterine growths by the hysteroscopic resectoscope.

F D Loffer1.   

Abstract

Fifty-three patients underwent 55 procedures with a resectoscope for the removal of large symptomatic intrauterine growths. The presenting complaint was menorrhagia, menometrorrhagia, or heavy postmenopausal bleeding in 38 patients; excessive menses plus infertility in 13 patients; and infertility alone in two patients. Forty-three patients had pedunculated or sessile submucous myomas and ten patients had large endometrial polyps. The long-term results are based on 45 patients followed for longer than 1 year. Excessive bleeding was controlled in 40 of the 43 women (93%). Failure to control abnormal bleeding was apparent within the first year. Seven of the 12 infertility patients (58%) delivered live-born infants. Five patients have undergone subsequent hysterectomies (9%). Two patients had repeat resectoscopic removal of myomas and two had subsequent non-resectoscope myomectomies. No major complications were encountered.

Entities:  

Mesh:

Year:  1990        PMID: 2216235     DOI: 10.1097/00006250-199011000-00023

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  [Hysteroscopic surgery].

Authors:  R Kimmig
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

2.  Risk Factors for the Completion of the Cold Loop Hysteroscopic Myomectomy in a One-Step Procedure: A Post Hoc Analysis.

Authors:  Ivan Mazzon; Alessandro Favilli; Mario Grasso; Stefano Horvath; Vittorio Bini; Gian Carlo Di Renzo; Sandro Gerli
Journal:  Biomed Res Int       Date:  2018-05-20       Impact factor: 3.411

3.  Clinical evaluation of improved MyoSure hysteroscopic tissue removal system for the resection of type II submucosal myomas.

Authors:  Yufei Liang; Yuefang Ren; Zeqiu Wan; Lihua Guo; Jie Dong; Yun Chen; Liping Lv
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.